CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award | +4,769 | 38,204 | ||
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −47 | $323.62 | $15K | 38,157 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −90 | $324.65 | $29K | 38,067 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −258 | $325.63 | $84K | 37,809 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −392 | $326.81 | $128K | 37,417 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −329 | $327.67 | $108K | 37,088 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −100 | $328.71 | $33K | 36,988 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −170 | $329.71 | $56K | 36,818 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −81 | $330.85 | $27K | 36,737 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −94 | $331.93 | $31K | 36,643 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −37 | $332.64 | $12K | 36,606 |
| 2026-03-02 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +10,480 | 10,480 | ||
| 2026-03-02 | SUPRAN BRYAN EVP, CLO and Secretary | Grant or award | +1,539 | 14,565 | ||
| 2026-03-02 | SUPRAN BRYAN EVP, CLO and Secretary | Grant or award · Stock Option (right to buy) | +3,381 | 3,381 | ||
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Grant or award | +13,844 | 105,427 | ||
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −200 | $323.62 | $65K | 105,227 |
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −382 | $324.65 | $124K | 104,845 |
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,098 | $325.63 | $358K | 103,747 |
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,669 | $326.81 | $545K | 102,078 |
| 2026-03-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,399 | $327.67 | $458K | 100,679 |
Page 8 of 41 · 816 trades